TRIUMPH-1 highlights the importance of options and the potential for retatrutide to help people across various stages of their obesity journey, said Kenneth Custer, an executive vice president of Eli Lilly and president of Lilly Cardiometabolic Health, in a statement
Individual timing depends on several factors, including your starting dose, body composition, digestive health, and whether you've eaten recently
Disclaimer: The information provided here is for general knowledge only and should not be considered medical advice
Over 68 weeks, the semaglutide group lost an average of 14.9 percent of body weight versus 2.4 percent on placebo
A registered dietitian can help you create a plan that promotes safe, sustainable weight loss without compromising your milk supply